CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells

British Journal of Cancer

Volumn 94, Issue 11, 2006, Pages 1627-1636

  Fontijn, D ^a   Duyndam, M C A ^a   Van Berkel, M P A ^a   Yuana, Y ^a   Shapiro, L H ^b   Pinedo, H M ^a   Broxterman, H J ^a   Boven, E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

bFGF; CD13; Invasion; Melanoma

Indexed keywords

AMINOPEPTIDASE; ANTIBODY; BASIC FIBROBLAST GROWTH FACTOR; BESTATIN; MATRIGEL; MESSENGER RNA; MICROSOMAL AMINOPEPTIDASE; UNCLASSIFIED DRUG; WM15 ANTIBODY;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANTIGENS, CD13; CELL LINE, TUMOR; CELL MOVEMENT; COLLAGEN; DACTINOMYCIN; DRUG COMBINATIONS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; HUMANS; LAMININ; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROMOTER REGIONS (GENETICS); PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; TRANSFECTION;

EID: 33745272527     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603157     Document Type: Article

References (39)

1. Bhagwat SV, Lahdenranta J, Giordano R, Arap W, Pasqualini R, Shapiro LH (2001) CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood 97: 652-659
2. Bhagwat SV, Petrovic N, Okamoto Y, Shapiro LH (2003) The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis. Blood 101: 1818-1826
3. Bikfalvi A, Klein S, Pintucci G, Rifkin DB (1997) Biological roles of fibroblast growth factor-2. Endocr Rev 18: 26-45
4. Bradford MA (1976) Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 7: 248-254
5. Bugler B, Amalric F, Prats H (1991) Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol Cell Biol 11: 573-577
6. Delmas B, Gelfi J, L'Haridon R, Vogel LK, Sjostrom H, Noren O, Laude H (1992) Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 357: 417-420
7. Elder DE, Rodeck U, Thurin J, Cardillo F, Clark WH, Stewart R, Herlyn M (1989) Antigenic profile of tumour progression stages in human melanocytic nevi and melanomas. Cancer Res 49: 5091-5096
8. Florkiewicz RZ, Baird A, Gonzalez AM (1991) Multiple forms of bFGF: differential nuclear and cell surface localization. Growth Factors 4: 265-275
9. Fujii H, Nakajima M, Aoyagi T, Tsuruo T (1996) Inhibition of tumour cell invasion and matrix degradation by aminopeptidase inhibitors. Biol Pharm Bull 19: 6-10
10. Fujii H, Nakajima M, Saiki I, Yoneda J, Azuma I, Tsuruo T (1995) Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13. Clin Exp Metast 13: 337-344
11. Halaban R (1996) Growth factors and melanomas. Semin Oncol 23: 673-681
12. Hansen AS, Noren O, Sjostrom H, Werdelin O (1993) A mouse aminopeptidase N is a marker for antigen-presenting cells and appears to be co-expressed with major histocompatibility complex class II molecules. Eur J Immunol 23: 2358-2364
13. Hashida H, Takabayashi A, Kanai M, Adachi M, Kondo K, Kohno N, Yamaoka Y, Miyake M (2002) Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Gastroenterology 122: 376-386
14. Ichinose Y, Genka K, Koike T, Kato H, Watanabe Y, Mori T, Lioka S, Sakuma A, Ohta M (2003) Randomized double-blind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma. J Natl Cancer Inst 95: 605-610
15. Ikeda N, Nakajima Y, Tokuhara T, Hattori N, Sho M, Kanehiro H, Miyake M (2003) Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma. Clin Cancer Res 9: 1503-1508
16. Ishii K, Usui S, Sugimura Y, Yoshida S, Hioki T, Tatematsu M, Yamamoto H, Hirano K (2001) Aminopeptidase N regulated by zinc in human prostate participates in tumour cell invasion. Int J Cancer 92: 49-54
17. Kehlen A, Lendeckel U, Dralle H, Langner J, Hoang-Vu C (2003) Biological significance of aminopeptidase N/CD13 in thyroid carcinomas. Cancer Res 63: 8500-8506
18. Larsen SL, Pedersen LO, Buus S, Stryhn A (1996) T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides. J Exp Med 184: 183-189
19. Lockshin A, Giovanella BC, De Ipolyi PD, Williams LJ, Mendoza JT, Yim SO, Stehlin JS (1985) Exceptional lethality for nude mice of cells derived from a primary human melanoma. Cancer Res 45: 345-350
20. Matsas R, Stephenson SL, Hryszko J, Kenny AJ, Turner AJ (1985) The metabolism of neuropeptides. Phase separation of synaptic membrane preparations with Triton X-114 reveals the presence of aminopeptidase N. Biochem J 231: 445-449
21. Menrad A, Speicher D, Wacker J, Herlyn M (1993) Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res 53: 1450-1455
22. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63
23. Ota K (1991) Review of ubenimex (Bestatin): clinical research. Biomed Pharmacother 45: 55-60
24. Ota K, Kurita S, Yamada K, Masaoka T, Uzuka Y, Ogawa N (1986) Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults. Cancer Immunol Immunother 23: 5-10
25. Pasqualini R, Koivunen E, Kain R, Lahdenranta J, Sakamoto M, Stryhn A, Ashmun RA, Shapiro LH, Arap W, Ruoslahti E (2000) Aminopeptidase N is a receptor for tumour-homing peptides and a target for inhibiting angiogenesis. Cancer Res 60: 722-727
26. Petrovic N, Bhagwat SV, Ratzan WJ, Ostrowski MC, Shapiro LH (2003) CD13/APN transcription is induced by RAS/MAPK-mediated phosphorylation of Ets-2 in activated endothelial cells. J Biol Chem 278: 49358-49368
27. 2-terminal extension of high molecular weight bFGF is a nuclear targeting signal. J Cell Physiol 147: 311-318
28. Renko M, Quarto N, Morimoto T, Rifkin DB (1990) Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol 144: 108-114
29. Riemann D, Kehlen A, Langner J (1999) CD13 - not just a marker in leukemia typing. Immunol Today 20: 83-88
30. Rodeck U (1993) Growth factor independence and growth regulatory pathways in human melanoma development. Cancer Metast Rev 12: 219-226
31. Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T, Azuma I (1993) Role of aminopeptidase N (CD13) in tumour-cell invasion and extracellular matrix degradation. Int J Cancer 54: 137-143
32. Scornik OA, Botbol V (2001) Bestatin as an experimental tool in mammals. Curr Drug Metab 2: 67-85
33. Shapiro LH, Arap W, Ruoslahti E (1991) Separate promoters control transcription of the human aminopeptidase N gene in myeloid and intestinal epithelial cells. J Biol Chem 266: 11999-12007
34. Turner AJ (1986) Processing and metabolism of neuropeptides. Essays Biochem 22: 69-119
35. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3(RESEARCH0034): 1-11
36. Van Hensbergen Y, Broxterman HJ, Hanemaaijer R, Jorna AS, van Lent NA, Verheul HM, Pinedo HM, Hoekman K (2002) Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoural fluid. Clin Cancer Res 812: 3747-3754
37. Van Hensbergen Y, Broxterman HJ, Peters E, Rana S, Elderkamp YW, van Hinsbergh VW, Koolwijk P (2003) Aminopeptidase inhibitor bestatin stimulates microvascular endothelial cell invasion in a fibrin matrix. Thromb Haemost 90: 921-929
38. Van Hensbergen Y, Broxterman HJ, Rana S, van Diest PJ, Duyndam MC, Hoekman K, Pinedo HM, Boven E et al. (2004) Reduced growth, increased vascular area, and reduced response to cisplatin in CD13-overexpressing human ovarian cancer xenografts. Clin Cancer Res 10: 1180-1191
39. Van Muijen GN, Jansen KF, Cornelissen IM, Smeets DF, Beck JL, Ruiter DJ (1991) Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int J Cancer 48: 85-91